ArticleInternational journal of oncology2019

The novel prognostic marker, EHMT2, is involved in cell proliferation via HSPD1 regulation in breast cancer.

Seon-Kyu Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.